Probiotic products that have strong scientific backing for health claims, innovative delivery formats and added functionalities via vitamins or botanicals have a strong basis to anticipate successful commercialisation in the post-pandemic era, according...
A combination of data from human clinical trials, microbiome analysis, and biomarkers are needed to better understand needs of consumers and formulate suitable probiotic and similar products for them.
The crucial role of microbiota metabolites, and the potential for new technology to create personalised solutions based on scientists understanding of them, has been highlighted by a leading academic from Japan.
Products with Food for Specified Health Uses (FOSHU or TOKUHO) claims still represent the largest share in the health foods and supplements market, although products with Food with Function Claims (FFC) have been growing steadily since 2015.
Current microbiome analysis methods are lacking high-resolution measurements and are unlikely to yield clinically relevant data in many conditions, but genome guided metagenomic analysis could address these current limitations.
Researchers from India have discovered that a diet high in flavonoids may contribute to the low prevalence of colorectal cancer (CRC) in the Indian population.
French probiotic firm TargEDys is conducting an ongoing clinical trial to study the benefits of its probiotic strain on weight reduction in overweight subjects, as part of its ambition to help tackle the global obesity issue.
The growing body evidence supporting the benefits of probiotics for prenatal health are opening up “exciting and unique” opportunities for new product development, according to an industry expert from DuPont.
The consumption of plant foods rich in fibre and polyphenols, as well as probiotic supplementation, has been identified as beneficial to restore microbiota balance in the gut and improve sleep, according to researchers.
The growth of probiotics brands online in Asia is heavily and positively impacted by higher star ratings and the number of product reviews, meaning brands need to pay significant attention to such consumer feedback for regional success.
The potential for probiotics to offer considerable benefits for prenatal health will be the topic of a keynote presnentation at our forthcoming Probiota Asia Summit in Singapore.
The potential for probiotics and prebiotics to deliver significant benefits to people suffering from chronic kidney conditions, and the emerging science behind the gut-kidney axis, will be the subject of a keynote presentation at our forthcoming Probiota...
Probiotics could play a more useful role when it comes to treating patients with more severe symptoms of depression, as compared to those with less severe scores, said a medical professional.
Experts gathered to discuss the potential and developments in the probiotics industry, highlighting regulations, trial design and costs as three areas to pay attention to in improving the industry's prospects.
Co-culturing yeast along with probiotics in foods and beverages could help to maintain the potency of the latter during the manufacture and distribution of probiotic products, according to a food science expert.
NutraIngredients, backed by trade association Global Organization for EPA and DHA Omega-3s (GOED), is to hold its inaugural Omega-3 summit in February 2019 in Singapore, with a host of top speakers already on board.
There are just two weeks to go until the region’s leading probiotic and microbiome event, Probiota Asia, gets underway in Singapore, with a stellar line-up of speakers from the likes of Blackmores, Danone, Herbalife and Life-Space set to take to the stage.
A leading expert from Australia's Commonwealth Scientific and Industrial Research Organisation (CSIRO) will reveal the emerging opportunities to modify gut microbial populations in a keynote address at the second edition of Probiota Asia in Singapore.
